Identification and Resolution of Drug-Related Problems among Childhood Cancer Patients in Ethiopia.
Journal
Journal of oncology
ISSN: 1687-8450
Titre abrégé: J Oncol
Pays: Egypt
ID NLM: 101496537
Informations de publication
Date de publication:
2020
2020
Historique:
received:
15
10
2019
revised:
11
02
2020
accepted:
24
02
2020
entrez:
8
4
2020
pubmed:
8
4
2020
medline:
8
4
2020
Statut:
epublish
Résumé
Even though medications play a major role in the cure, palliation, and inhibition of disease, they also expose patients to drug-related problems. Drug-related problems are frequent and may result in reduced quality of life, morbidity, and mortality. The study was aimed to identify, characterize, and resolve drug-related problems in the Pediatric Hematology/Oncology ward of Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia. A prospective observational study was conducted from 25 June to 25 October 2018 to assess DRPs on patients admitted at the pediatric hematology/oncology ward of Tikur Anbessa Specialized Hospital, which is the highest level governmental tertiary care hospital in Ethiopia. Data were obtained from patients' medical charts, physicians, patients/caregivers, pharmacists, and nurses. All the collected data were entered and analyzed using the Statistical Package for the Social Sciences version 25e. Descriptive statistics were used to represent the data. Among the total 156 participants, DRPs were identified in 68.6% of the study subjects. Dosing problems which include dosage too low and high were the top ranking (39.3%) of all DRPs followed by needs additional therapy (27.2%) and nonadherence (14.0%). Systemic anti-infectives were the most common class of drugs involved in DRPs. Trimethoprim-sulfamethoxazole, methotrexate, vincristine, ondansetron, and metoclopramide were frequently involved in DRPs. The addition of drugs and change in drug dose were the two most proposed intervention types. Among the proposed interventions, 223 (92.15%) were fully accepted, 9 (3.72%) partially accepted, and 10 (4.13%) not accepted. DRPs are common among Pediatric Hematology/Oncology ward patients. The hospital should develop a pediatric dosing chart for the commonly prescribed medications to prevent drug-related morbidity and mortality. The integration of clinical pharmacists can mitigate risks associated with DRPs.
Sections du résumé
BACKGROUND
BACKGROUND
Even though medications play a major role in the cure, palliation, and inhibition of disease, they also expose patients to drug-related problems. Drug-related problems are frequent and may result in reduced quality of life, morbidity, and mortality.
OBJECTIVES
OBJECTIVE
The study was aimed to identify, characterize, and resolve drug-related problems in the Pediatric Hematology/Oncology ward of Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia.
METHODS
METHODS
A prospective observational study was conducted from 25 June to 25 October 2018 to assess DRPs on patients admitted at the pediatric hematology/oncology ward of Tikur Anbessa Specialized Hospital, which is the highest level governmental tertiary care hospital in Ethiopia. Data were obtained from patients' medical charts, physicians, patients/caregivers, pharmacists, and nurses. All the collected data were entered and analyzed using the Statistical Package for the Social Sciences version 25e. Descriptive statistics were used to represent the data.
RESULTS
RESULTS
Among the total 156 participants, DRPs were identified in 68.6% of the study subjects. Dosing problems which include dosage too low and high were the top ranking (39.3%) of all DRPs followed by needs additional therapy (27.2%) and nonadherence (14.0%). Systemic anti-infectives were the most common class of drugs involved in DRPs. Trimethoprim-sulfamethoxazole, methotrexate, vincristine, ondansetron, and metoclopramide were frequently involved in DRPs. The addition of drugs and change in drug dose were the two most proposed intervention types. Among the proposed interventions, 223 (92.15%) were fully accepted, 9 (3.72%) partially accepted, and 10 (4.13%) not accepted.
CONCLUSION
CONCLUSIONS
DRPs are common among Pediatric Hematology/Oncology ward patients. The hospital should develop a pediatric dosing chart for the commonly prescribed medications to prevent drug-related morbidity and mortality. The integration of clinical pharmacists can mitigate risks associated with DRPs.
Identifiants
pubmed: 32256586
doi: 10.1155/2020/6785835
pmc: PMC7102482
doi:
Types de publication
Journal Article
Langues
eng
Pagination
6785835Informations de copyright
Copyright © 2020 Malede Berihun Yismaw et al.
Déclaration de conflit d'intérêts
The authors declare that they have no conflicts of interest.
Références
Pediatrics. 2014 Mar;133(3):e716-24
pubmed: 24488741
Einstein (Sao Paulo). 2018;16(1):eAO4122
pubmed: 29694617
Br J Clin Pharmacol. 2004 May;57(5):611-5
pubmed: 15089814
J Oncol Pract. 2018 Mar;14(3):e130-e136
pubmed: 29400987
Pediatr Blood Cancer. 2017 Jul;64(7):
pubmed: 28205376
J Res Pharm Pract. 2015 Oct-Dec;4(4):216-21
pubmed: 26645029
J Adv Pharm Technol Res. 2015 Oct-Dec;6(4):190-4
pubmed: 26605161
PLoS One. 2014 Oct 08;9(10):e110168
pubmed: 25296280
JAMA. 1997 Jan 22-29;277(4):312-7
pubmed: 9002494
Pharm World Sci. 2008 Apr;30(2):161-8
pubmed: 17906939
Drugs Real World Outcomes. 2017 Jun;4(2):97-107
pubmed: 28527149
J Oncol Pharm Pract. 2019 Sep;25(6):1312-1320
pubmed: 29984626
J Clin Oncol. 2015 Sep 20;33(27):3065-73
pubmed: 26304881
Br J Clin Pharmacol. 2014 May;77(5):873-9
pubmed: 24868576
Int J Clin Pharm. 2017 Oct;39(5):1039-1046
pubmed: 28689305
Anticancer Res. 2015 Jan;35(1):457-60
pubmed: 25550587
Gynecol Oncol Res Pract. 2017 Oct 18;4:15
pubmed: 29075505
JAMA Oncol. 2018 Nov 1;4(11):1553-1568
pubmed: 29860482
J Am Pharm Assoc (Wash). 2001 Mar-Apr;41(2):192-9
pubmed: 11297331
Lancet Oncol. 2012 Aug;13(8):790-801
pubmed: 22658655
Support Care Cancer. 2018 Aug;26(8):2737-2742
pubmed: 29488017
Pediatr Blood Cancer. 2018 Apr;65(4):
pubmed: 29251399
J Basic Clin Pharm. 2016 Dec;8(1):15-19
pubmed: 28104969
J Oncol Pharm Pract. 2015 Apr;21(2):93-101
pubmed: 24477774